Home › Funds › Yiheng Capital Management, L.P. › DBVT

Yiheng Capital Management, L.P. position in DBVT

DBV TECHNOLOGIES S A · Health Care

Yiheng Capital Management, L.P. reported holding 170,142 shares of DBVT (DBV TECHNOLOGIES S A) in its Q2 2026 13F filing — a position valued at US$2.8M, representing 1.27% of its reported portfolio and ranking #21 among its reported holdings. Yiheng Capital Management, L.P. has disclosed DBVT holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)170.14K sh
Reported value held$2.79M
Portfolio Weight1.27%
First reportedQ3 2023
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Yiheng Capital Management, L.P.'s DBVT position evolved

Yiheng Capital Management, L.P. first disclosed a stake in DBVT in Q3 2023 at 133,192 shares (US$181K). The position peaked in Q4 2025 at 639,769 shares, worth US$12.3M. Across 12 filings, Yiheng Capital Management, L.P. increased the stake 2 time(s), trimmed it 4 time(s) and left it unchanged 5 time(s). The most recent filing (Q2 2026) shows 170,142 shares valued at US$2.8M. Notable position changes include a 3835% increase in Q4 2023 (shares fell 21% over the following quarter), a 79% trim in Q4 2024 (shares rose 121% over the following quarter), a 73% trim in Q1 2026 (shares fell 21% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 133.19K $181.14K New
Q4 2023 5.24M $4.99M Add
Q1 2024 5.57M $4.17M Add
Q2 2024 3.15M $2.53M Reduce
Q3 2024 3.15M $2.21M Hold
Q4 2024 656.31K $2.03M Reduce
Q1 2025 656.31K $4.48M Hold
Q2 2025 656.31K $6.01M Hold
Q3 2025 656.31K $6.56M Hold
Q4 2025 639.77K $12.26M Reduce
Q1 2026 170.14K $3.55M Reduce
Q2 2026 170.14K $2.79M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About DBVT and 13F data

DBVT (DBV TECHNOLOGIES S A) is a Health Care company. 57 other funds we track also report a position in DBVT — the largest reported positions include MPM BioImpact LLC (US$60.1M), Siren, L.L.C. (US$30.5M), Vivo Capital, LLC (US$30.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding DBVT

All DBVT fund holders →

FAQ

How long has Yiheng Capital Management, L.P. held DBVT?

Yiheng Capital Management, L.P. has disclosed DBVT holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Yiheng Capital Management, L.P.'s current position in DBVT?

As of Q2 2026, Yiheng Capital Management, L.P. holds 170.14K shares of DBVT (DBV TECHNOLOGIES S A), valued at $2.79M, representing 1.27% of its reported portfolio and ranking #21.

Has Yiheng Capital Management, L.P. been buying or selling DBVT?

In the latest 13F filing (Q2 2026), Yiheng Capital Management, L.P. held unchanged its position in DBVT. The position peaked in Q4 2025 at 639.77K shares.

Which other funds hold DBVT?

Other major institutional holders of DBVT include MPM BioImpact LLC, Siren, L.L.C., Vivo Capital, LLC, among 57 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.